Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Japan’s Development Bank invests in Indian real estate through HDFC Capital fund
Japan's Development Bank of Japan Inc. has entered India's residential property market. It committed capital to HDFC Capital's affordable and mid-income housing platform. This marks a significant new entry of Japanese institutional capital. The investment supports sustainable development and addresses India's housing shortage. It also enhances geographic diversification for the bank's overseas real estate portfolio.
Tata-backed MedTherapy claims CAR-T breakthrough with one-day production
Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can reduce production time from several weeks to just one day and cut costs by nearly 70%, potentially making advanced cancer treatment more affordable.
Govt health spending triples to Rs 3.85 lakh crore in 2022-23: National Health Accounts
Government spending on healthcare has surged to Rs 3.85 lakh crore in 2022-23, nearly tripling from a decade ago. This increased public investment has led to a substantial drop in household out-of-pocket expenses for treatment. The share of government health spending in GDP has also risen. This indicates a positive shift towards more affordable and accessible healthcare for all citizens.
Bernstein says Aadhar Housing, Home First, other housing stocks can rally up to 34%. Here are 3 reasons why
Bernstein sees a significant rally potential of up to 34% in affordable housing finance stocks like Home First Finance and Aptus Value Housing. Favorable trends, improving business momentum, and stable operating conditions are driving this optimism. Despite attractive valuations, the sector benefits from low mortgage penetration and a strong competitive moat.
What Rs 1,100 Gets You In China: Indian Vlogger’s Tour Of Affordable Yet Stylish Hotel Amazes Internet
Duplex-style hotel room in Chengdu, China, for just Rs 1,100 per night
Gold, silver rates today rise up to 4% as WTI crude oil prices tank 5% on US-Iran deal buzz
Gold Rate Today: The dollar weakened, making greenback-priced bullion more affordable for holders of other currencies. Spot gold prices rallied 1.4% to $4,570.88 per ounce, while US gold futures for June delivery gained 1.1% to $4,572.90.
S&P flags pressure on Indian Oil as high crude prices squeeze margins
S&P Global Ratings warns Indian Oil Corporation faces mounting pressure to balance affordable fuel with profitability. Prolonged Middle East tensions are escalating crude oil prices, squeezing margins and potentially impacting IOC's earnings and liquidity over the next year. The agency highlights the challenge of absorbing losses from high crude costs while meeting India's energy needs.
Alembic gets USFDA nod for generic levothyroxine sodium tablets
Alembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medication is used as a replacement therapy for hypothyroidism. The approval covers multiple strengths of the tablets. This development is significant for patients seeking affordable treatment options. The market for these tablets is substantial.
Interest subvention scheme likely for e-buses, e-trucks; Centre may earmark ₹6,960 cr
The government is weighing cheaper loans and other incentives to help private operators buy electric buses and trucks, aiming to cut fossil fuel use and boost cleaner transport. Officials believe the proposed support could make costly EV fleets more affordable and unlock large private investments in commercial electric mobility.
India’s realty boom may need Rs 50 lakh crore in fresh capital over next decade
India's real estate sector requires Rs 50 lakh crore capital for growth over the next decade. Data centres, logistics, industrial real estate, and GCC-led office developments will attract significant long-term investment. Despite challenges, strong domestic demand and infrastructure investments will drive growth. The focus is on channeling capital to affordable housing and emerging cities.
Star Health and Allied Insurance rolls out 20% cheaper health cover for tier-2, tier-3 cities
Star Health and Allied Insurance is launching an affordable health insurance product for tier-2 and tier-3 cities, with premiums 20% lower than existing plans. This move aims to increase insurance penetration in smaller towns where affordability is a key barrier. The insurer is also developing a preferred hospital network called Pratham to enhance customer experience.
AbbVie loses patent plea for Hep C drug
The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to affordable treatment for millions. The patent office refused the application after AbbVie failed to contest oppositions and chose to abandon it. This refusal prevents AbbVie from extending its patent monopoly by five years.